• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Anaesth Crit Care Pain Med . Clinical, obstetrical and anaesthesia outcomes in pregnant women during the first COVID-19 surge in France: a prospect

tetano

Editor, Senior Moderator
Anaesth Crit Care Pain Med


. 2021 Aug 12;100937.
doi: 10.1016/j.accpm.2021.100937. Online ahead of print.
Clinical, obstetrical and anaesthesia outcomes in pregnant women during the first COVID-19 surge in France: a prospective multicentre observational cohort study


Hawa Keita[SUP] 1 [/SUP], Arthur James[SUP] 2 [/SUP], Lionel Bouvet[SUP] 3 [/SUP], Emilie Herrmann[SUP] 4 [/SUP], Agnès Le Gouez[SUP] 5 [/SUP], Jean-Xavier Mazoit[SUP] 6 [/SUP], Frédéric-Jean Mercier[SUP] 5 [/SUP], Dan Benhamou[SUP] 6 [/SUP], Obstetric Anaesthesia COVID-19 Collaboration Network



Affiliations

Abstract

Introduction: Clinical outcomes and critical care utilisation associated with Coronavirus Disease 2019 (COVID-19) in obstetric patients remain limited particularly in relation to severe cases.
Methods: A retrospective multicentre cohort study was conducted during the first wave of COVID-19 in France in 18 tertiary referral maternity units. Consecutive women with confirmed or suspected COVID-19 during pregnancy or the delivery hospitalisation were included between March and July 2020 (17-week period). We report clinical, obstetrical and anaesthetic outcomes of pregnant women with COVID-19 and report the prevalence of severe forms and risk factors for respiratory support in this cohort.
Results: There were 126 included cases; RT-PCR testing occurred in 82 cases, of which 64 (78%) had a positive test. The caesarean section rate was 52%, and preterm delivery (< 37 weeks) rate was 40%. Neuraxial anaesthesia was performed in 108 (86%) cases with an increasing proportion compared to general anaesthesia over time (p < 0.0002). Twenty-eight cases received oxygen supplementation (nasal oxygen therapy or mechanical ventilation); the SOFAresp score was associated with gestational age at the time of COVID-19 presentation (p = 0.0036) and at delivery (p < 0.0001). Postpartum intensive care unit (ICU) admission occurred in 21 cases (17%) with 17 (13%) receiving invasive or non-invasive ventilation. Pre-delivery factors associated with postpartum ventilation were oxygen support, oxygen saturation and haemoglobin levels.
Conclusion: In our cohort, COVID-19 was associated with significant maternal morbidity resulting in high ICU admission rates (17%) and invasive or non-invasive ventilation utilisation (10%).

Keywords: COVID-19; Caesarean section; Critical care; Labour; Pregnancy; SARS-CoV-2; SOFAresp; Ventilation.
 
Back
Top Bottom